Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity

Nucleic Acids Research

Volumn 31, Issue 12, 2003, Pages 3063-3070

  Campillos, Mónica ^a   Lamas, José Ramón ^a   García, Miguel Angel ^a   Bullido, María Jesús ^a   Valdivieso, Fernando ^a   Vázquez, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DNA; GUANINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; TYROSINE; UNCLASSIFIED DRUG; HELICASE; HNRNP A1; NUCLEAR PROTEIN; RECOMBINANT PROTEIN; RIBONUCLEOPROTEIN; THYMUS HORMONE;

AFFINITY CHROMATOGRAPHY; ALLELE; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HEART INFARCTION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LEUKEMIA CELL LINE; MASS SPECTROMETRY; MODULATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RISK ASSESSMENT; T LYMPHOCYTE; TELOMERE; TRANSACTIVATION; BINDING SITE; CELL CULTURE; GENETICS; METABOLISM; REGULATORY SEQUENCE;

ALLELES; APOLIPOPROTEINS E; BINDING SITES; DNA HELICASES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; JURKAT CELLS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RIBONUCLEOPROTEINS; THYMUS HORMONES; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0038239281     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg435     Document Type: Article

References (43)

1. Mahley, R.W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 240, 622-630.
2. Weisgraber, K.H. (1994) Apolipoprotein E: structure-function relationships. Adv. Protein Chem., 45, 249-302.
3. Masliah, E., Mallory, M., Aford, M., Veinbergs, I. and Roses, A.D. (1996) In Roses, A.D., Weisgraber, K.H. and Christen, Y. (eds), Apolipoprotein E and Alzheimer's Disease. Springer Verlag, Berlin, Germany, pp. 59-73.
4. Das, H.K., McPherson, J., Bruns, G.A., Karathanasis, S.K. and Breslow, J.L. (1985) Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem., 260, 6240-6247.
5. Davignon, J., Gregg, R.E. and Sing, C.F. (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis, 8, 1-21.
6. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
7. Artiga, M.J., Bullido, M.J., Sastre, I., Recuero, M., García, M.A., Aldudo, J., Vázquez, J. and Valdivieso, F. (1998 Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett., 421, 105-108.
8. Artiga, M.J., Bullido, M.J., Frank, A., Sastre, I., Recuero, M., García, M.A., Lendon, C.L., Han, S.W., Morris, J.C., Vázquez, J., Goate, A. and Valdivieso, F. (1998) Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum. Mol. Genet., 7, 1887-1892.
9. Bullido, M.J., Artiga, M.J., Recuero, M., Sastre, I., García, M.A., Aldudo, J., Lendon, C., Han, S.W., Morris, J.C., Frank, A., Vázquez, J., Goate, A. and Valdivieso, F. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature Genet., 18, 69-71.
10. Bullido, M.J. and Valdivieso, F. (2000) Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease. Microsc. Res. Tech., 50, 261-267.
11. Lambert, J.C., Brousseau, T., Defosse, V., Evans, A., Arveiler, D., Ruidavets, J.B., Haas, B., Cambou, J.P., Luc, G., Ducimetiere, P., Cambien, F., Chartier-Harlin, M.C. and Amouyel, P. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum. Mol. Genet., 9, 57-61.
12. Viitanen, L., Pihlajamaki, J., Miettinen, R., Karkkainen, P., Vauhkonen, I., Halonen, P., Kareinen, A., Lehto, S. and Laakso, M. (2001) Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease. J. Mol. Med., 79, 732-737.
13. Laws, S.M., Taddei, K., Martins, G., Paton, A., Fisher, C., Clarnette, R., Hallmayer, J., Brooks, W.S., Gandy, S.E. and Martins, R.N. (1999) The -491A/T polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport, 10, 879-882.
14. García, M.A., Vázquez, J., Giménez, C., Valdivieso, F. and Zafra, F. (1996) Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J. Neurosci., 16, 7550-7556.
15. Municio, M.M., Lozano, J., Sánchez, P., Moscat, J. and Díaz-Meco, M.T. (1995) Identification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C ζ. J. Biol. Chem., 270, 15884-15891.
16. García, M.A., Campillos, M., Marina, A., Valdivieso, F. and Vázquez, J. (1999) Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS Lett., 444, 27-31.
17. Piñol-Roma, S., Choi, Y.D., Matunis, M.J. and Dreyfuss, G. (1988) Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev., 2, 215-227.
18. Del Gatto-Konczak, F., Olive, M., Gesnel, M.C. and Breathnach, R. (1999) hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol., 19, 251-260.
19. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
20. Shevchenko, A., Wilm, M., Vorm, O. and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem., 68, 850-858.
21. Marina, A., García, M.A., Albar, J.P., Yague, J., López De Castro, J.A. and Vázquez, J. (1999) High-sensitivity analysis and sequencing of peptides and proteins by quadrupole ion trap mass spectrometry. J. Mass Spectrom., 34, 17-27.
22. Yang, X., Bani, M.R., Lu, S.J., Rowan, S., Ben-David, Y. and Chabot, B. (1994) The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5′ splice site selection in vivo. Proc. Natl Acad. Sci. USA, 91, 6924-6928.
23. Riva, S., Morandi, C., Tsoulfas, P., Pandolfo, M., Biamonti, G., Merrill, B., Williams, K.R., Multhaup, G., Beyreuther, K., Werr, H. et al. (1986) Mammalian single-stranded DNA binding protein UP I is derived from the hnRNP core protein A1. EMBO J., 5, 2267-2273.
24. Herrick, G. and Alberts, B. (1976) Purification and physical characterization of nucleic acid helix-unwinding proteins from calf thymus. J. Biol. Chem., 251, 2124-2132.
25. Herrick, G., Delius, H. and Alberts, B. (1976) Single-stranded DNA structure and DNA polymerase activity in the presence of nucleic acid helix-unwinding proteins from calf thymus. J. Biol. Chem., 251, 2142-2146.
26. Detera, S.O., Becerra, S.P., Swack, J.A. and Wilson, S.H. (1981) Studies on the mechanism of DNA polymerase α. Nascent chain elongation, steady state kinetics, and the initiation phase of DNA synthesis. J. Biol. Chem., 256, 6933-6943.
27. Pontius, B.W. and Berg, P. (1990) Renaturation of complementary DNA strands mediated by purified mammalian heterogeneous nuclear ribonucleoprotein A1 protein: implications for a mechanism for rapid molecular assembly. Proc. Natl Acad. Sci. USA, 87, 8403-8407.
28. Labranche, H., Dupuis, S., Ben-David, Y., Bani, M.R., Wellinger, R.J. and Chabot, B. (1998) Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nature Genet., 19, 199-202.
29. Ben-David, Y., Bani, M.R., Chabot, B., De Koven, A. and Bernstein, A. (1992) Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth. Mol. Cell. Biol., 12, 4449-4455.
30. Li, Y.J., Pak, B.J., Higgins, R.R., Lu, S.J. and Ben-David, Y. (2001) Contiguous arrangement of p45 NFE2, HnRNP A1 and HP1 alpha on mouse chromosome 15 and human chromosome 12: evidence for suppression of these genes due to retroviral integration within the Fli-2 locus. Genes Chromosom. Cancer, 30, 91-95.
31. Bai, Y., Lee, D., Yu, T. and Chasin, L.A. (1999) Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1. Nucleic Acids Res., 27, 1126-1134.
32. Hay, D.C., Kemp, G.D., Dargemont, C. and Hay, R.T. (2001) Interaction between hnRNPA1 and IκBα is required for maximal activation of NF-κB-dependent transcription. Mol. Cell. Biol., 21, 3482-3490.
33. Chen, H., Hu, B., Allegretto, E.A. and Adams, J.S. (2000) The vitamin D response element-binding protein. A novel dominant-negative regulator of vitamin D-directed transactivation. J. Biol. Chem., 275, 35557-35564.
34. Lau, J.S., Baumeister, P., Kim, E., Roy, B., Hsieh, T.Y., Lai, M. and Lee, A.S. (2000) Heterogeneous nuclear ribonucleoproteins as regulators of gene expression through interactions with the human thymidine kinase promoter. J. Cell. Biochem., 79, 395-406.
35. Donev, R., Horton, R., Beck, S., Doneva, T., Vatcheva, R., Bowen, W.R. and Sheer, D. (2003) Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex. J. Biol. Chem., 278, 5214-5226.
36. Idriss, H., Kumar, A., Casas-Finet, J.R., Guo, H., Damuni, Z. and Wilson, S.H. (1994) Regulation of in vitro nucleic acid strand annealing activity of heterogeneous nuclear ribonucleoprotein protein A1 by reversible phosphorylation. Biochemistry, 33, 11382-11390.
37. Cartegni, L., Maconi, M., Morandi, E., Cobianchi, F., Riva, S. and Biamonti, G. (1996) hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J. Mol. Biol., 259, 337-348.
38. Kamma, H., Portman, D.S. and Dreyfuss, G. (1995) Cell type-specific expression of hnRNP proteins. Exp. Cell Res., 221, 187-196.
39. Abdul-Manan, N. and Williams, K.R. (1996) hnRNP A1 binds promiscuously to oligoribonucleotides: utilization of random and homo-oligonucleotides to discriminate sequence from base-specific binding. Nucleic Acids Res., 24, 4063-4070.
40. Burd, C.G., Swanson, M.S., Gorlach, M. and Dreyfuss, G. (1989) Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1 and C2 proteins: A diversity of RNA binding proteins is generated by small peptide inserts. Proc. Natl Acad. Sci. USA, 86, 9788-9792.
41. Ding, J., Hayashi, M.K., Zhang, Y., Manche, L., Krainer, A.R. and Xu, R.M. (1999) Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with single-stranded telomeric DNA. Genes Dev., 13, 1102-1115.
42. Lambert, J.C., Pasquier, F., Cottel, D., Frigard, B., Amouyel, P. and Chartier-Harlin, M.C. (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum. Mol. Genet., 7, 533-540.
43. Lambert, J.C., Mann, M., Goumidi, J., Harris, J., Amouyel, P., Iwatsubo, T., Lendon, C. and Chartier-Harlin, M.C. (2001) Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet, 357, 608-609.